10 results match your criteria: "UCLA Center for Excellence in Pancreatic Diseases[Affiliation]"
Pancreas
August 2021
UCLA Center for Excellence in Pancreatic Diseases, University of California, Los Angeles, Los Angeles, CA.
The potential of artificial intelligence (AI) applied to clinical data from electronic health records (EHRs) to improve early detection for pancreatic and other cancers remains underexplored. The Kenner Family Research Fund, in collaboration with the Cancer Biomarker Research Group at the National Cancer Institute, organized the workshop entitled: "Early Detection of Pancreatic Cancer: Opportunities and Challenges in Utilizing Electronic Health Records (EHR)" in March 2021. The workshop included a select group of panelists with expertise in pancreatic cancer, EHR data mining, and AI-based modeling.
View Article and Find Full Text PDFPancreas
March 2021
Gastrointestinal Cancer Center, Dana-Farber Cancer Institute, Boston, MA.
Despite considerable research efforts, pancreatic cancer is associated with a dire prognosis and a 5-year survival rate of only 10%. Early symptoms of the disease are mostly nonspecific. The premise of improved survival through early detection is that more individuals will benefit from potentially curative treatment.
View Article and Find Full Text PDFPancreas
April 2014
From the *UCLA Sleep Disorders Center, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA; †International Center for Metabolic Diseases, School of Biotechnology, Beijiao Hospital, Southern Medical University, Guangzhou, People's Republic of China; ‡Cedars-Sinai MedicalCenter, Los Angeles, CA; §Department of Neurobiology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA; and ∥Department of Medicine, UCLA Center for Excellence in Pancreatic Diseases, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA.
Type 2 diabetes mellitus (T2DM) and obstructive sleep apnea (OSA) are both common major public health concerns. Epidemiological and clinical evidence postulates that OSA may be a causal factor in the pathogenesis of T2DM. This review examines recent empirical developments in theory, research, and practice regarding T2DM and OSA.
View Article and Find Full Text PDFPancreas
November 2013
From the *American Pancreatic Association, University of Minnesota, Minneapolis, MN; and †UCLA Center for Excellence in Pancreatic Diseases, Los Angeles, CA.
Curr Drug Targets
December 2012
UCLA Center for Excellence in Pancreatic Diseases, Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, California 90095, USA.
Despite advances in therapy for many of the most common cancers, advances which have led to corresponding improvements in survival rates, progress on the pancreatic cancer front have been slow and mortality rates remain startlingly high. New therapeutic strategies are needed. Phytochemicals are naturally occurring, plant-based substances that have garnered much interest in the research world for their anti-cancer properties, both as therapeutics and as components of the diet for chemoprevention.
View Article and Find Full Text PDFBiochim Biophys Acta
August 2011
Department of Surgery, UCLA Center for Excellence in Pancreatic Diseases, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Scutellaria baicalensis (SB) and SB-derived polyphenols possess anti-proliferative activities in several cancers, including pancreatic cancer (PaCa). However, the precise molecular mechanisms have not been fully defined. SB extract and SB-derived polyphenols (wogonin, baicalin, and baicalein) were used to determine their anti-proliferative mechanisms.
View Article and Find Full Text PDFSurgery
May 2011
Hirshberg Laboratories for Pancreatic Cancer Research, Department of Surgery, UCLA Center for Excellence in Pancreatic Diseases, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
Background: The role of N-myc downstream regulated gene-1 (NDRG1) in cancer has recently gained interest, as potential regulator of cell death and tumor suppressor. Although its normal function in the pancreas is largely unknown, loss of NDRG1 expression is associated with a more aggressive tumor phenotype and poor outcome in pancreatic cancer patients.
Methods: NDRG1 expression was determined in human pancreatic cancer samples and across a panel of 6 pancreatic cancer cell lines.
Endocrinol Metab Clin North Am
December 2010
UCLA Center for Excellence in Pancreatic Diseases, Los Angeles, CA 90095-1786, USA.
Gastroenteropancreatic (GEP) neuroendocrine tumors (NETs) are relatively rare neoplasms that characteristically synthesize and secrete an excess of a variety of regulatory peptides, hormones, and neuroamines, which regulate gut and pancreatic function. This excess can lead to distinct clinical syndromes. Therapeutic strategies include surgery, radiofrequency ablation, chemotherapy, chemoembolization, and biotherapy using somatostatin analogs.
View Article and Find Full Text PDFMol Imaging Biol
December 2010
Hirshberg Laboratory for Pancreatic Cancer Research, Department of Surgery, UCLA Center for Excellence in Pancreatic Diseases, David Geffen School of Medicine, University of California-Los Angeles, 675 Charles E. Young Drive South, Los Angeles, CA 90095, USA.
Purpose: Angiogenesis is essential for physiological processes as well as for carcinogenesis. New approaches to cancer therapy include targeting angiogenesis. One target is VEGF-A and its receptor VEGFR2.
View Article and Find Full Text PDFDig Dis
August 2011
Southern California Research Center for Alcoholic Liver Pancreatic Diseases and Cirrhosis, UCLA Center for Excellence in Pancreatic Diseases, University of California, and VA Greater Los Angeles Health Care System, Los Angeles, Calif., USA.
Alcohol abuse is a common cause of both acute and chronic pancreatitis. There is a wide spectrum of pancreatic manifestations in heavy drinkers from no apparent disease in most individuals to acute inflammatory and necrotizing pancreatitis in a minority of individuals with some progressing to chronic pancreatitis characterized by replacement of the gland by fibrosis and chronic inflammation. Both smoking and African-American ethnicity are associated with increased risk of alcoholic pancreatitis.
View Article and Find Full Text PDF